I. Introduction. Current status of medical mycology in Mexico;I. Introducción. Importancia actual de la micología médica en México

Gaceta Medica de Mexico

Volumn 144, Issue 2, 2008, Pages 121-122

  López Martínez, Rubén ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; MYCOTOXIN; PYRROLE DERIVATIVE;

ALLERGY; ANTIFUNGAL RESISTANCE; CONFERENCE PAPER; DERMATOMYCOSIS; DISEASE CLASSIFICATION; HUMAN; INCIDENCE; INFECTION RISK; MEXICO; MYCOLOGY; MYCOSIS; MYCOTOXICOSIS; RISK FACTOR; SYMPTOMATOLOGY; ARTICLE; FUNGUS; IMMUNE DEFICIENCY; IMMUNOLOGY; ISOLATION AND PURIFICATION; MICROBIOLOGY; MOLECULAR BIOLOGY; MYCETOMA; OPPORTUNISTIC INFECTION; SOCIOECONOMICS;

FUNGI; HUMANS; IMMUNOCOMPROMISED HOST; MADUROMYCOSIS; MEXICO; MOLECULAR BIOLOGY; MYCOSES; OPPORTUNISTIC INFECTIONS; SOCIOECONOMIC FACTORS;

EID: 50949084233     PISSN: 00163813     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (13)

1. Pelroth J, Choi B, Spellberg B. Nosocomial fungal infections: epidemiology, diagnosis and treatment. Med Mycol 2007;45:321-346.
2. Sepkowitz, KA. Opportunistic infections in patients with and patients without acquired immunodeficiency syndrome. Clin Infect Dis 2002;34:1098-1107.
3. López-Martínez R. Las micosis en la época del sida. Rev Med IMSS 2000;38:421-423.
4. Manzano-Gayosso P, Hernández-Hernández F, Méndez-Tovar LJ, González-Monrroy J, López-Martínez R. Fungal peritonitis in 15 patients on continuous ambulatory peritoneal diagnosis (CAPD). Mycoses 2002;46:425-429.
5. Lumbreras C, Gavalda J. Aspergilosis invasiva: manifestaciones clínicas y tratamiento. Rev Iberoamer Micol 2003;20:79-89.
6. a edición. México: Trillas; 2004.
7. Bonifaz A, Carrasco-Gerard E, Saul A. Chromoblastomycosis: clinical and mycology experience of 51 cases. Mycoses 2001;44:1-7.
8. Hidalgo A. Radiología de las infecciones fúngicas invasoras del aparato respiratorio. Rev Iberoamer Micol 2007;24:14-18.
9. Velasco-Rodríguez VM, Martínez-Ordaz VA, Padua y Gabriel A, Lazo-Sáenz JG, Cicero-Sabido R. Usefulness of the coccidioidin skin test in patients with type diabetes mellitus in an endemic zone. Rev Invest Clin 2001;53:223-227.
10. Sánchez-García M. Efecto clínico de la candidosis invasora en el paciente crítico no neutropénico. Rev Iberoamer Micol 2006;23:8-11.
11. Pfaller MA, Diekema DJ. Rare and emerging opportunistic fungal pathogens: concern for resistance beyond Candida albicans and Aspergillus fumigatus. J Clin Microbiol 2004;42:4419-4431.
12. Chakrabarti A. Microbiology of systemic fungal infections. J Postgrad Med 2005;51:S16-S20.
13. a edición. México: McGraw Hill; 2004.